» Articles » PMID: 11276207

A Pathological Function for Eotaxin and Eosinophils in Eosinophilic Gastrointestinal Inflammation

Overview
Journal Nat Immunol
Date 2001 Mar 29
PMID 11276207
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Although eosinophils have been implicated in the pathogenesis of gastrointestinal disorders, their function has not been established. Using a murine model of oral antigen-induced eosinophil-associated gastrointestinal disease, we report the pathological consequences of eosinophilic inflammation and the involvement of eotaxin and eosinophils. Exposure of mice to enteric-coated antigen promotes an extensive T helper 2-associated eosinophilic inflammatory response involving the esophagus, stomach, small intestine and Peyer's patches as well as the development of gastric dysmotility, gastromegaly and cachexia. Electron microscopy shows eosinophils in proximity to damaged axons, which indicated that eosinophils were mediating a pathologic response. In addition, mice deficient in eotaxin have impaired eosinophil recruitment and are protected from gastromegaly and cachexia. These results establish a critical pathological function for eotaxin and eosinophils in gastrointestinal allergic hypersensitivity.

Citing Articles

Clinical characteristics of patients with eosinophilic esophagitis and eosinophilic esophageal myositis based on esophageal motility.

Kawami N, Hoshikawa Y, Momma E, Tanabe T, Koeda M, Hoshino S Esophagus. 2024; 22(1):124-130.

PMID: 39438425 DOI: 10.1007/s10388-024-01093-5.


From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis.

Barchi A, Mandarino F, Yacoub M, Albarello L, Massimino L, Savarino E Biomolecules. 2024; 14(9).

PMID: 39334846 PMC: 11429508. DOI: 10.3390/biom14091080.


Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report.

Takedomi H, Fukuda K, Inoue S, Tsuruoka N, Sakata Y, Aoki S Intest Res. 2024; 23(1):107-111.

PMID: 39205502 PMC: 11834364. DOI: 10.5217/ir.2024.00013.


Balancing immune responses: regulatory cells in eosinophilic gastrointestinal disorders.

Kheshtchin N, Kanannejad Z, Ghahramani Z, Esmaeilzadeh H, Sepahi N Front Immunol. 2024; 15:1372009.

PMID: 39136025 PMC: 11317405. DOI: 10.3389/fimmu.2024.1372009.


Coeliac disease is a strong risk factor for Gastro-oesophageal reflux disease while a gluten free diet is protective: a systematic review and meta-analysis.

Irani M, Eslick G, Burns G, Potter M, Halland M, Keely S EClinicalMedicine. 2024; 71:102577.

PMID: 38659976 PMC: 11039972. DOI: 10.1016/j.eclinm.2024.102577.